153 related articles for article (PubMed ID: 1374293)
21. T cell receptor V beta gene utilization in myelin basic protein specific clones from CXJ1 recombinant inbred mice.
Kalman B; Knobler RL; Lublin FD
J Neuroimmunol; 1993 Mar; 43(1-2):191-4. PubMed ID: 7681448
[TBL] [Abstract][Full Text] [Related]
22. A myelin oligodendrocyte glycoprotein peptide induces typical chronic experimental autoimmune encephalomyelitis in H-2b mice: fine specificity and T cell receptor V beta expression of encephalitogenic T cells.
Mendel I; Kerlero de Rosbo N; Ben-Nun A
Eur J Immunol; 1995 Jul; 25(7):1951-9. PubMed ID: 7621871
[TBL] [Abstract][Full Text] [Related]
23. T-cell receptor (TCR) usage in Lewis rat experimental autoimmune encephalomyelitis: TCR beta-chain-variable-region V beta 8.2-positive T cells are not essential for induction and course of disease.
Gold R; Giegerich G; Hartung HP; Toyka KV
Proc Natl Acad Sci U S A; 1995 Jun; 92(13):5850-4. PubMed ID: 7597040
[TBL] [Abstract][Full Text] [Related]
24. Characterization of the immune response to a secondary encephalitogenic epitope of basic protein in Lewis rats. II. Biased T cell receptor V beta expression predominates in spinal cord infiltrating T cells.
Gold DP; Vainiene M; Celnik B; Wiley S; Gibbs C; Hashim GA; Vandenbark AA; Offner H
J Immunol; 1992 Mar; 148(6):1712-7. PubMed ID: 1371786
[TBL] [Abstract][Full Text] [Related]
25. T cell receptor (TCR) usage determines disease susceptibility in experimental autoimmune encephalomyelitis: studies with TCR V beta 8.2 transgenic mice.
Kuchroo VK; Collins M; al-Sabbagh A; Sobel RA; Whitters MJ; Zamvil SS; Dorf ME; Hafler DA; Seidman JG; Weiner HL
J Exp Med; 1994 May; 179(5):1659-64. PubMed ID: 8163944
[TBL] [Abstract][Full Text] [Related]
26. Restricted T-cell receptor V beta gene usage by myelin basic protein-specific T-cell clones in multiple sclerosis: predominant genes vary in individuals.
Ben-Nun A; Liblau RS; Cohen L; Lehmann D; Tournier-Lasserve E; Rosenzweig A; Zhang JW; Raus JC; Bach MA
Proc Natl Acad Sci U S A; 1991 Mar; 88(6):2466-70. PubMed ID: 1706524
[TBL] [Abstract][Full Text] [Related]
27. 'Lupus-prone' mice are susceptible to organ-specific autoimmune disease, experimental allergic encephalomyelitis.
Zamvil SS; al-Sabbagh A; Nelson PA; Kaul D; Charles MS; Mitchell DJ; Steinman L; Weiner HL; Kuchroo VK
Pathobiology; 1994; 62(3):113-9. PubMed ID: 7524528
[TBL] [Abstract][Full Text] [Related]
28. Identification of encephalitogenic V beta-4-bearing T cells in SJL mice. Further evidence for the V region disease hypothesis?
Padula SJ; Lingenheld EG; Stabach PR; Chou CH; Kono DH; Clark RB
J Immunol; 1991 Feb; 146(3):879-83. PubMed ID: 1703184
[TBL] [Abstract][Full Text] [Related]
29. Induction of a heterogeneous TCR repertoire in (PL/JXSJL/J)F1 mice by myelin basic protein peptide Ac1-11 and its analog Ac1-11[4A].
Pearson CI; Smilek DE; Danska JS; McDevitt HO
Mol Immunol; 1997 Aug; 34(11):781-92. PubMed ID: 9444977
[TBL] [Abstract][Full Text] [Related]
30. Pathologic role and temporal appearance of newly emerging autoepitopes in relapsing experimental autoimmune encephalomyelitis.
Vanderlugt CL; Neville KL; Nikcevich KM; Eagar TN; Bluestone JA; Miller SD
J Immunol; 2000 Jan; 164(2):670-8. PubMed ID: 10623809
[TBL] [Abstract][Full Text] [Related]
31. Tracking of V beta 8.2-positive encephalitogenic T cells by complementarity-determining region 3 spectratyping and subsequent Southern blot hybridization in Lewis rats after neuroantigen sensitization.
Sakuma H; Kohyama K; Jee Y; Matsumoto Y
J Immunol; 2004 Oct; 173(7):4516-22. PubMed ID: 15383583
[TBL] [Abstract][Full Text] [Related]
32. Experimental allergic encephalomyelitis induced by the peptide encoded by exon 2 of the MBP gene, a peptide implicated in remyelination.
Segal BM; Raine CS; McFarlin DE; Voskuhl RR; McFarland HF
J Neuroimmunol; 1994 Apr; 51(1):7-19. PubMed ID: 7512579
[TBL] [Abstract][Full Text] [Related]
33. An alpha-chain TCR CDR3 peptide can enhance EAE induced by myelin basic protein or proteolipid protein.
Yamamura T; Geng TC; Kozovska MF; Yokoyama K; Cohen IR; Tabira T
J Neurosci Res; 1996 Sep; 45(6):706-13. PubMed ID: 8892082
[TBL] [Abstract][Full Text] [Related]
34. Epitope spreading occurs in active but not passive EAE induced by myelin basic protein.
Voskuhl RR; Farris RW; Nagasato K; McFarland HF; Dalcq MD
J Neuroimmunol; 1996 Nov; 70(2):103-11. PubMed ID: 8898718
[TBL] [Abstract][Full Text] [Related]
35. Diverse T cell receptor beta chain usage by rat encephalitogenic T cells reactive to residues 68-88 of myelin basic protein.
Sun D; Le J; Coleclough C
Eur J Immunol; 1993 Feb; 23(2):494-8. PubMed ID: 7679647
[TBL] [Abstract][Full Text] [Related]
36. Cloning of myelin basic protein-reactive T cells from the experimental allergic encephalomyelitis-resistant rat strain, LER.
Blankenhorn EP; Stranford SA; Martin AM; Hickey WF
J Neuroimmunol; 1995 Jun; 59(1-2):173-83. PubMed ID: 7541054
[TBL] [Abstract][Full Text] [Related]
37. Both rat and mouse T cell receptors specific for the encephalitogenic determinant of myelin basic protein use similar V alpha and V beta chain genes even though the major histocompatibility complex and encephalitogenic determinants being recognized are different.
Burns FR; Li XB; Shen N; Offner H; Chou YK; Vandenbark AA; Heber-Katz E
J Exp Med; 1989 Jan; 169(1):27-39. PubMed ID: 2462609
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of experimental autoimmune encephalomyelitis in Lewis rats by nasal administration of encephalitogenic MBP peptides: synergistic effects of MBP 68-86 and 87-99.
Liu JQ; Bai XF; Shi FD; Xiao BG; Li HL; Levi M; Mustafa M; Wahren B; Link H
Int Immunol; 1998 Aug; 10(8):1139-48. PubMed ID: 9723700
[TBL] [Abstract][Full Text] [Related]
39. Mechanisms of acquired thymic tolerance in experimental autoimmune encephalomyelitis: thymic dendritic-enriched cells induce specific peripheral T cell unresponsiveness in vivo.
Khoury SJ; Gallon L; Chen W; Betres K; Russell ME; Hancock WW; Carpenter CB; Sayegh MH; Weiner HL
J Exp Med; 1995 Aug; 182(2):357-66. PubMed ID: 7543136
[TBL] [Abstract][Full Text] [Related]
40. Predicting the effects of potentially therapeutic modified peptides on polyclonal T cell populations in a mouse model of multiple sclerosis.
Sauer EL; Trifilieff E; Greer JM
J Neuroimmunol; 2017 Jun; 307():18-26. PubMed ID: 28495132
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
